Injeq is developing the IQ‑Tip, a "smart needle" intended to reduce blind punctures. The company expects regulatory approval for the IQ‑Tip in early 2021. Injeq has completed multiple crowdfunding rounds and this was its third. The firm raised capital via the Invesdor platform, drawing broad retail investor interest. Management is considering a larger funding round or possibly a public offering. The company is based in Finland and reached a pre‑money valuation of €11.56 million in this raise.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2020